More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$3.61B
EPS
0.09
P/E ratio
246
Price to sales
1.39
Dividend yield
--
Beta
1.02623
Previous close
$22.14
Today's open
$22.18
Day's range
$21.76 - $22.30
52 week range
$14.22 - $22.68
show more
CEO
Paul Keel
Employees
12300
Headquarters
Brea, CA
Exchange
New York Stock Exchange
Shares outstanding
164426233
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Envista Holdings Corporation (NVST) Presents at Evercore 8th Annual Healthcare Conference Transcript
Envista Holdings Corporation (NVST) Presents at Evercore 8th Annual Healthcare Conference Transcript
Seeking Alpha • Dec 3, 2025

Here's Why Envista (NVST) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Nov 28, 2025

Envista Announces Participation in 8th Annual Evercore Healthcare Conference
BREA, Calif. , Nov. 25, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the 8th Annual Evercore Healthcare Conference.
PRNewsWire • Nov 25, 2025

Envista Holdings Corporation (NVST) Q3 2025 Earnings Call Transcript
Envista Holdings Corporation ( NVST ) Q3 2025 Earnings Call October 30, 2025 5:00 PM EDT Company Participants Jim Gustafson - Vice President of Investor Relations Paul Keel - CEO & Director Eric Hammes - Senior VP & CFO Conference Call Participants Allen Lutz - BofA Securities, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Michael Cherny - Leerink Partners LLC, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Linda Bolduc - Morgan Stanley, Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Steven Valiquette - Mizuho Securities USA LLC, Research Division Michael Sarcone - Jefferies LLC, Research Division Russell Yuen - William Blair & Company L.L.C.
Seeking Alpha • Oct 31, 2025

Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Oct 31, 2025

Envista Reports Third Quarter 2025 Results
BREA, Calif. , Oct. 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended September 26, 2025.
PRNewsWire • Oct 30, 2025

Envista Announces Release of 2024 Sustainability Report
BREA, Calif. , Oct. 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced the release of its 2024 Sustainability Report, highlighting ongoing efforts to pursue progress with purpose as it integrates sustainable and responsible business practices to achieve its mission of partnering with professionals to improve lives.
PRNewsWire • Oct 29, 2025

Envista (NVST) Earnings Expected to Grow: Should You Buy?
Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Investment Research • Oct 23, 2025

Will Envista (NVST) Beat Estimates Again in Its Next Earnings Report?
Envista (NVST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks Investment Research • Oct 20, 2025

NVST or ABT: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Abbott (ABT). But which of these two stocks is more attractive to value investors?
Zacks Investment Research • Oct 15, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Envista Holdings Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.